WCN26-5945 EVALUATING THE CLINICAL, ECONOMIC, AND ENVIRONMENTAL IMPACT OF GUIDELINE-DIRECTED THERAPY IN JAPAN: AN IMPACT CKD ANALYSIS

Read full text Summarise with VIRAT
Authors: Kei Nagai, Shingo Shoji, Noriharu Chishima, Stacey Priest, Keisuke Nansai, Kouichi Tamura
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) is an increasing health concern in Japan due to the ageing population. A global simulation study suggests that 6.9% to 59.3% increase in people with CKD G3-5 and 3.6% to 170.8% increase of patients on dialysis between 2022 and 2032 across eight countries, however, also suggests that improved implementation of guideline-directed medical therapy (GDMT) for CKD could yield significant clinical, economic, and environmental benefits by delaying disease progression and reducing clinical events.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104839–104839
Publication date
25 March 2026
Language
EN